Bioextrax AB (publ) (STO:BIOEX)

Bioextrax AB Statistics

Total Valuation

Bioextrax AB has a market cap or net worth of SEK 120.91 million. The enterprise value is 109.35 million.

Market Cap	120.91M
Enterprise Value	109.35M

Important Dates

The next estimated earnings date is Friday, June 5, 2026.

Earnings Date	Jun 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioextrax AB has 47.60 million shares outstanding. The number of shares has increased by 15.44% in one year.

Current Share Class	47.60M
Shares Outstanding	47.60M
Shares Change (YoY)	+15.44%
Shares Change (QoQ)	+20.17%
Owned by Insiders (%)	19.62%
Owned by Institutions (%)	16.44%
Float	37.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	91.18
PB Ratio	7.16
P/TBV Ratio	7.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.06
EV / Sales	82.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.14

Financial Position

The company has a current ratio of 6.32

Current Ratio	6.32
Quick Ratio	5.73
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18,179.00

Financial Efficiency

Return on equity (ROE) is -92.65% and return on invested capital (ROIC) is -58.33%.

Return on Equity (ROE)	-92.65%
Return on Assets (ROA)	-53.08%
Return on Invested Capital (ROIC)	-58.33%
Return on Capital Employed (ROCE)	-107.66%
Weighted Average Cost of Capital (WACC)	12.91%
Revenue Per Employee	94,714
Profits Per Employee	-1.29M
Employee Count	14
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.06% in the last 52 weeks. The beta is 1.57, so Bioextrax AB's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	-13.06%
50-Day Moving Average	2.60
200-Day Moving Average	2.64
Relative Strength Index (RSI)	47.69
Average Volume (20 Days)	90,443

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioextrax AB had revenue of SEK 1.33 million and -18.05 million in losses. Loss per share was -0.44.

Revenue	1.33M
Gross Profit	170,000
Operating Income	-18.18M
Pretax Income	-18.05M
Net Income	-18.05M
EBITDA	-17.08M
EBIT	-18.18M
Loss Per Share	-0.44

Balance Sheet

The company has 11.56 million in cash and n/a in debt, with a net cash position of 11.56 million or 0.24 per share.

Cash & Cash Equivalents	11.56M
Total Debt	n/a
Net Cash	11.56M
Net Cash Per Share	0.24
Equity (Book Value)	16.89M
Book Value Per Share	0.37
Working Capital	11.25M

Cash Flow

In the last 12 months, operating cash flow was -13.24 million and capital expenditures -198,000, giving a free cash flow of -13.44 million.

Operating Cash Flow	-13.24M
Capital Expenditures	-198,000
Depreciation & Amortization	1.10M
Net Borrowing	n/a
Free Cash Flow	-13.44M
FCF Per Share	-0.28

Margins

Gross Margin	12.82%
Operating Margin	-1,370.97%
Pretax Margin	-1,361.01%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioextrax AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.44%
Shareholder Yield	-15.44%
Earnings Yield	-14.93%
FCF Yield	-11.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 22, 2021. It was a forward split with a ratio of 4.

Last Split Date	Jul 22, 2021
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	3